PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-369

  1. 1,659 Posts.
    lightbulb Created with Sketch. 177
    It appears 51 Capital now also have much
    concern that 2x2 was not included in the dose
    study.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.